Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sarkis Meterissian Insider Profile
4 Followers
Sarkis Meterissian, Director at Defence Therapeutics, holds 192.00K shares in Defence Therapeutics (Ticker: DTCFF).
Sarkis Meterissian Defence Therapeutics (DTCFF)Director
Defence Therapeutics (DTCFF)
Director
Ranked #24,847 out of 99,335 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+78.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Sarkis Meterissian's holdings
Insider Roles
Director
Roles that Sarkis Meterissian holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sarkis Meterissian
Sarkis Meterissian's Trading History
List of latest transactions for each holding click on a transaction to see Sarkis Meterissian's performance on stock
You May Also Like
Sarkis Meterissian insider profile FAQ
What is the percentage of profitable transactions made by Sarkis Meterissian?
The percentage of profitable transactions made by Sarkis Meterissian is 100%.
What is the average return per transaction made by Sarkis Meterissian?
The average return per transaction made by Sarkis Meterissian is 78.80%.
What stocks does Sarkis Meterissian hold?
Sarkis Meterissian holds: DTCFF stocks.
What was Sarkis Meterissian’s latest transaction?
Sarkis Meterissian latest transaction was an Uninformative Sell of $125.00K.
What was Sarkis Meterissian's most profitable transaction?
Sarkis Meterissian’s most profitable transaction was an Informative Sell of DTCFF stock on November 25, 2023. The return on the trade was 79.80%.
What is Sarkis Meterissian's role in Defence Therapeutics?
Sarkis Meterissian's role in Defence Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.